Quick Answer
Jaguar Health, Inc. reported Earnings Per Share Diluted of $130.69 (loss) per share for the year ending 2024.
- Jaguar Health, Inc. showed an increase of +95.1% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Jaguar Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $0.30 (loss) per share | Q3 2017: $1.11 per share | Q3 2018: $0.51 (loss) per share | Q2 2020: $0.44 (loss) per share | Q3 2020: $0.62 (loss) per share | Q1 2021: $0.28 (loss) per share | Q2 2021: $0.31 (loss) per share | Q3 2021: $0.27 (loss) per share | Q1 2022: $23.10 (loss) per share | Q2 2022: $8.77 (loss) per share | Q3 2022: $8.83 (loss) per share | Q1 2023: $2.39 (loss) per share | Q2 2023: $41.35 (loss) per share | Q3 2023: $22.50 (loss) per share | Q1 2024: $87.12 (loss) per share | Q2 2024: $2.66 (loss) per share | Q3 2024: $26.29 (loss) per share | Q1 2025: $16.70 (loss) per share | Q2 2025: $10.26 (loss) per share | Q3 2025: $6.28 (loss) per share.
- Over the full 5 years of available data (2020 to 2024), Jaguar Health, Inc.'s Earnings Per Share Diluted has declined by 4,256.3%.
- Historical annual values: Fiscal year 2024: $130.69 (loss) per share | Fiscal year 2023: $2,678.17 (loss) per share | Fiscal year 2022: $36.18 (loss) per share | Fiscal year 2021: $88.22 (loss) per share | Fiscal year 2020: $3.00 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: